A child left severely disabled due to the absence of a newborn screening test for a muscle wasting disease in the NHS has prompted a parent to hold “years of delays” responsible. The Mirror has initiated a campaign advocating for the inclusion of spinal muscular atrophy (SMA) in the NHS newborn heel prick test, a practice already implemented in many developed countries. Five-year-old Ollie Williams suffers from Type 1 SMA, rendering him reliant on external support for basic functions like breathing, eating, and sitting. His delayed SMA diagnosis resulted in irreversible damage to his motor neurons during his early weeks of life.
Ben and Amy, Ollie’s parents, are determined to prevent similar tragedies from befalling other children in the UK, where an estimated 33 infants end up in wheelchairs annually due to the absence of comprehensive newborn screening. While Scotland has committed to nationwide SMA screening, the UK National Screening Committee has opted for a phased approach, conducting an NHS pilot in select regions of England and Wales.
The committee’s insistence on extensive data collection before implementing SMA screening has drawn criticism from Ben, who highlights the unnecessary disability and potential fatalities resulting from delayed diagnoses. The recent revelation of ex-Little Mix singer Jesy Nelson’s twins being diagnosed late with SMA underscores the urgency for proactive screening measures.
Ollie’s daily life involves intensive care, including physiotherapy sessions to maintain muscle function, the use of specialized equipment like a power chair, and precautionary measures to prevent infections. The Mirror’s ongoing coverage of the issue underscores the urgency of incorporating SMA screening into the NHS newborn testing regimen to prevent lifelong disability in children.
While the UK lags behind in SMA screening compared to many other nations, the availability of advanced treatments underscores the critical importance of early detection. The Department of Health and Social Care has initiated a large-scale study into newborn SMA screening, with plans to screen hundreds of thousands of infants as part of an NHS trial. The commitment to timely diagnoses and improved support for affected families remains a top priority.
The situation highlights the necessity for swift action to address the gaps in newborn screening protocols and ensure that all infants receive comprehensive testing to identify potential health conditions early on.